APO Summer School 2018
The fourth annual APO Summer School conference was held in Prague, on 30 August 2018, intended for representatives of Czech patient organisations and other interested parties from the area of Czech Healthcare.
The main topic of this year’s APO Summer School was: Involvement of patient organisations, medical societies and the public in the process of Health Technology Assessment (HTA).
Over 120 people participated in this year’s APO summer school, representing patient organisations, the Czech Medical Association of J. E. Purkyně, the Czech Ministry of Health CR, the State Institute for Drug Control, the Czech Pharmacoeconomic Society, the European Parliament, industry, media and others.
Mr. Jakub Dvořáček, the Executive Director of AIFP, and Ms. Lenka Teska Arnoštová,, Chairperson of Company medical law at Czech. Medical Association JEP, opened the conference.
We were pleased to welcome three experts on involving patient organisations in the HTA process from Great Britain, France and Scotland.
The first speaker was Karen Facey, PhD. from Great Britain, co-author of the professional publication “Patient Involvement in Health Technology Assessment”, discussing the following topic: How and why can patients and patient organisations be included in the HTA process?
This was followed by a presentation from Heidi Livingstone, BA from the British NICE (National Institute for Health and Care, Excellence) focussing on the topic: How to help patient organisations take part more effectively.
And our last foreign expert was Hervé Nabarette, PhD., from AFM-Téléthon, representing patients involved in HTA in France. Hervé’s lecture was on the topic: A new approach to patient involvement in HTA, the pricing and coverage determination process in France.
An important part of the programme was the roundtable on the topic of patient involvement in the HTA process, which included representatives from:
- The Patient’s Council of the Czech Minister of Health CR
- The Czech Ministry of Health CR
- The Czech Medical Association of J. E. Purkyně
- The State Institute for Drug Control
Part of the roundtable included a discussion with the audience and foreign experts.
Ms. Kateřina Konečná, member of European Parliament also accepted our invitation and relayed the current position of the European Parliament on patient involvement in HTA within Europe.
The last part of this conference was a presentation of the forthcoming HTA educational programme for patient organisations, which will take place during the autumn of 2018, under the auspices of the Ministry of Health CR. This programme is being prepared together with the Ministry of Health CR in cooperation with the Association of Innovative Pharmaceutical Industry, the Czech Medical Association of JEP, the Czech Pharmacoeconomic Society and foreign HTA experts.
Photographs from the left side:
Photo – Three experts Karen Facey Ph.D., Hervé Nabarette, Ph.D., Heidi Livingstone BA
with the Executive director of the Association of Innovative Pharmaceutical Industry Mr. Jakub Dvořáček.
Č. 1 – Mr. Jakub Dvořáček, the Executive director of the Association of Innovative Pharmaceutical Industry
Č. 2 – Ms. Lenka Teska Arnoštová, Chairperson of Company medical law at Czech Medical Association of J. E. Purkyně
Č. 3 – Karen Facey, Ph.D. – the expert on HTA programme from Great Britain
Č. 4 – Heidi Livingstone, BA – the British NICE (National Institute for Health and Care Excellence)
Č. 5 – Hervé Nabarette, Ph.D. – the Deputy Director of Public Affairs - AFM-Téléthon Francie.
Č. 6 – The foreign speakers with the Executive director of the Association of Innovative Pharmaceutical Industry Mr. Jakub Dvořáček.
Č. 7 – Foreign experts together with the representatives of the Czech healthcare professionals at the roundtable
Č. 8 – Representatives of the Patient Council of the Minister of Health
Č. 9 – Ms. Kateřina Konečná, Member of the European Parliament
Č. 10 – Mr. Jakub Dvořáček, the Executive Director of the Association of Innovative Pharmaceutical Industry together with Ms. Irena Storová, the Director of the State Institute for Drug Control and Mr. Radek Policar, the Deputy of Minister of Health